|
positive regulation of nitric oxide biosynthetic process
|
14
|
25.93
|
2.12 × 10−23
|
|
inflammatory response
|
20
|
37.04
|
1.89 × 10−18
|
|
positive regulation of transcription from RNA polymerase II promoter
|
26
|
48.15
|
1.90 × 10−17
|
|
positive regulation of smooth muscle cell proliferation
|
12
|
22.22
|
3.09 × 10−17
|
|
lipopolysaccharide-mediated signaling pathway
|
10
|
18.52
|
4.01 × 10−16
|
|
positive regulation of gene expression
|
16
|
29.63
|
1.99 × 10−15
|
|
response to drug
|
16
|
29.63
|
1.76 × 10−14
|
|
cellular response to lipopolysaccharide
|
12
|
22.22
|
4.69 × 10−14
|
|
response to lipopolysaccharide
|
13
|
24.07
|
9.47 × 10−14
|
|
positive regulation of transcription, DNA-templated
|
18
|
33.33
|
1.69 × 10−13
|
|
aging
|
12
|
22.22
|
3.15 × 10−12
|
|
cellular response to organic cyclic compound
|
9
|
16.67
|
1.11 × 10−11
|
|
angiogenesis
|
12
|
22.22
|
8.27 × 10−11
|
|
positive regulation of protein phosphorylation
|
10
|
18.52
|
2.04 × 10−10
|
|
movement of cell or subcellular component
|
9
|
16.67
|
2.49 × 10−10
|
|
response to antibiotic
|
7
|
12.96
|
6.28 × 10−10
|
|
negative regulation of apoptotic process
|
14
|
25.93
|
1.12 × 10−9
|
|
cellular response to mechanical stimulus
|
8
|
14.81
|
2.36 × 10−9
|
|
negative regulation of cell proliferation
|
13
|
24.07
|
2.79 × 10−9
|
|
positive regulation of ERK1 and ERK2 cascade
|
10
|
18.52
|
3.53 × 10−9
|
